Edge Capital Group’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3.47M Sell
194
-25,033
-99% -$3.66M 0.15% 108
2024
Q3
$3.89M Hold
25,227
0.17% 105
2024
Q2
$3.68M Hold
25,227
0.18% 106
2024
Q1
$3.73M Buy
+25,227
New +$3.62M 0.19% 105
2023
Q2
Sell
-1,788
Closed -$231K 405
2023
Q1
$231K Buy
+1,788
New +$234K 0.01% 284
2021
Q1
Sell
-2,246
Closed -$255K 298
2020
Q4
$255K Sell
2,246
-25
-1% -$2.73K 0.02% 228
2020
Q3
$240K Sell
2,271
-99
-4% -$10.4K 0.02% 214
2020
Q2
$237K Buy
+2,370
New +$234K 0.02% 197
2020
Q1
Sell
-1,964
Closed -$200K 241
2019
Q4
$200K Buy
+1,964
New +$189K 0.02% 222

Other funds holding XLV

Edge Capital Group's XLV Position: Q4 2024 in Review

Edge Capital Group reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 99% in Q4 2024, selling an estimated $3.66M and leaving 194 shares worth $3.47M. The position accounts for 0.15% of the portfolio, ranked #108.

Edge Capital Group first reported a position in XLV in Q4 2019 and has held it in 9 quarters since. The position peaked at $3.89M in Q3 2024. 1,759 funds tracked by Wall St. Rank hold XLV as of Q4 2024.

  • Edge Capital Group held 194 shares of State Street Health Care Select Sector SPDR ETF worth $3.47M as of Q4 2024.
  • Edge Capital Group sold 25,033 State Street Health Care Select Sector SPDR ETF shares in Q4 2024, an estimated $3.66M.
  • State Street Health Care Select Sector SPDR ETF made up 0.15% of Edge Capital Group's portfolio in Q4 2024, its #108 holding.
  • Edge Capital Group first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2019 and has held it in 9 quarters since.
  • Edge Capital Group's State Street Health Care Select Sector SPDR ETF position peaked at $3.89M in Q3 2024.
  • 1,759 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2024.

Based on Edge Capital Group's 13F filing for Q4 2024, filed 4 Feb 2025.